Evidence map›Paper›PMID 28774928›Full record

ArticleScience (New York, N.Y.)2017

The microbial metabolite desaminotyrosine protects from influenza through type I interferon.

Ashley L Steed, George P Christophi, Gerard E Kaiko, Lulu Sun, Victoria M Goodwin, Umang Jain, Ekaterina Esaulova, Maxim N Artyomov, David J Morales, Michael J Holtzman and 3 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 347 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
347citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

347 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Journal of pharmaceutical analysis · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

287 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Ashley L SteedDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-8314-2597
George P ChristophiDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-3945-4507
Gerard E KaikoDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-3167-3174
Lulu SunDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-7543-1532
Victoria M GoodwinDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-1730-1083
Umang JainDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Ekaterina EsaulovaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-9806-662X
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
David J MoralesDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-9941-4120
Michael J HoltzmanDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Adrianus C M BoonDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-4700-8224
Deborah J LenschowDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-9400-5309
Thaddeus S StappenbeckDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. stappenb@pathology.wustl.edu.ORCID 0000-0002-6023-3901

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
The role of CARDS toxin in genesis and exacerbation of allergic inflammationU19AI070412 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BASEMAN, JOEL BARRY · 2006 to 2015
$19.7M
Tissue and Cell Processing CoreU19AI070489 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2006 to 2016
$17.9M
CLINICAL/LABORATORY TRAINING ACADEMIC GASTROENTEROLOGYT32DK007130 · NIDDK · WASHINGTON UNIVERSITY · PI MATTHEW AARON CIORBA · 1986 to 2026
$8.3M
Preclinical Development of an Anti-Mucus DrugUH3HL123429 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2016 to 2018
$4.7M
PARP9-DTX3L Control Of Viral Infection and Airway DiseaseR01AI130591 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2017 to 2021
$3.0M
INTERFERON SIGNAL ENHANCERS AS ANTIVIRAL THERAPEUTICSR01AI111605 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2014 to 2017
$1.8M
NHLBI NIH HHS UH3 HL123429NIAID NIH HHS R01 AI111605NIAID NIH HHS R01 AI130591NIAID NIH HHS U19 AI070412NIAID NIH HHS U19 AI070489NICHD NIH HHS K12 HD000850NIDDK NIH HHS P30 DK056341NIDDK NIH HHS T32 DK007130
6 · The paper itself

Abstract

The microbiota is known to modulate the host response to influenza infection through as-yet-unclear mechanisms. We hypothesized that components of the microbiota exert effects through type I interferon (IFN), a hypothesis supported by analysis of influenza in a gain-of-function genetic mouse model. Here we show that a microbially associated metabolite, desaminotyrosine (DAT), protects from influenza through augmentation of type I IFN signaling and diminution of lung immunopathology. A specific human-associated gut microbe,

Indexed as

AnimalsCell LineClostridium perfringensGastrointestinal MicrobiomeGTP-Binding ProteinsHost-Pathogen InteractionsInterferon Type ILungMiceMice, KnockoutOrthomyxoviridae InfectionsPhenylpropionatesSignal TransductionGTP-Binding ProteinsIfi1 protein, mouseInterferon Type IPhenylpropionatesphloretic acid

Identifiers

PMID28774928
PMCPMC5753406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.